Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antibacterial
Biotech
Recce's synthetic gel treats skin infections in ph. 2
Recce’s synthetic anti-infective treated a range of skin infections in a mid-stage trial, setting the Australian biotech’s sights on a phase 3 trial.
James Waldron
Feb 19, 2025 8:39am
Basilea opts not to take MRSA antibiotic into clinic
Feb 18, 2025 4:08am
Destiny goes private to stay afloat after no partner found
Jul 15, 2024 4:33am
BiomX acquires fellow bacteria-killing virus company APT
Mar 6, 2024 9:01am
Boehringer rounds up allies to build €40M anti-superbug startup
Jul 6, 2022 6:01am
Stopping DNA 'packet' exchange could halt bacterial resistance
Jun 14, 2022 8:30am
